Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar 20;24(6):1101.
doi: 10.3390/molecules24061101.

Chromatographic Analysis and Anti-Oxidative Property of Naoxinqing Tablet, a Proprietary Preparation of Diospyros Kaki Leaves

Affiliations

Chromatographic Analysis and Anti-Oxidative Property of Naoxinqing Tablet, a Proprietary Preparation of Diospyros Kaki Leaves

Magdy Kazzem et al. Molecules. .

Abstract

The Naoxinqing (NXQ) tablet is a standardised proprietary herbal product containing an extract of persimmon leaves (Diospyros kaki) for the management of cardio- and cerebrovascular diseases. Although previous reports suggested that the efficacy of NXQ is at least partly mediated by its anti-oxidative property, the anti-oxidative effect of the major components of NXQ has not been studied systematically. For quality control purposes, only analytical methods limited to 3 marker analytes have been reported, the extent to which the other components affect efficacy has not been explored. In this study, we developed an ultra-performance liquid chromatography-tandem mass spectrometry (UPLC MS/MS) method for the identification of seven analytes (kaempferol-3-O-glucoside (astragalin), quercetin-3-O-galactoside (hypericin), quercetin-3-O-glucoside (isoquercitin), kaempferol, 3,4-dihydroxybenzoic acid (protocatechuic acid), and furan-2-carboxylic acid (pyromucic acid) and quercetin) in the NXQ. This is the first method reported and validated for the quantification of the seven major secondary metabolites in NXQ. The results for the quantified analytes were then compared in 15 different batches of NXQ. The variation observed in the seven components highlights the need to quantify key bioactive components to ensure product consistency. Radical scavenging activity and abundance was used to rank the analytes. The anti-oxidative effects of NXQ were examined using cultured human vascular endothelial cells (EA.hy926). Corrected 2,2-di(4-tert-octylphenyl)-1-picrylhydrazyl (DPPH) activity results revealed that quercetin and kaempferol have the strongest anti-oxidant capacity in the extract. Both quercetin and kaempferol significantly inhibited the hydrogen peroxide (H₂O₂)-induced EA.hy926 cell injury and intracellular reactive oxygen species (ROS) generation. In conclusion, we established and validated an UPLC-MS/MC method for the analysis of major bioactive components in the NXQ and demonstrated that its anti-oxidative property may play a critical role in cerebrovascular protection.

Keywords: Naoxinqing; UPLC MS/MC analysis; anti-oxidative; endothelial cells; reactive oxygen species.

PubMed Disclaimer

Conflict of interest statement

As a medical research institute, NICM Health Research Institute receives research grants and donations from foundations, universities, government agencies, individuals and industry. Sponsors and donors also provide untied funding for work to advance the vision and mission of the Institute. The authors declare no competing financial interests.

Figures

Figure 1
Figure 1
Ultra high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry (UPLC-ESI-MS/MS) chromatogram of NXQ extract.1 = Succinic acid, 2 = 3,4-dihydroxybenzoic acid, 3 = furan-2-carboxylic acid, 4 = quercetin-3-O-galactoside, 5 = quercetin-3-O-glucoside, 6 = quercetin-3-O-rutinoside, 7 = myricetin, 8 = kaempferol-3-O-glucoside, 9 = quercetin, 10 = kaempferol.
Figure 2
Figure 2
(A) Effects of NXQ (10–500 µg mL−1) on H2O2-induced intracellular ROS generation in EA.hy926 cells. (n = 3). Data are presented as means ± SD **p <0.001 vs control (CLT) group; ###p <0.001 vs. H2O2 group. (B) Effects of quercetin (10–500 µg mL−1) on H2O2-induced intracellular ROS generation in EA.hy926 cells. (n = 3). Data are presented as means ± S.D. *** p <0.0001 vs. control (CLT) group; ###p <0.001 vs. H2O2 group. (C) Effects of kaempferol (10–500 µg mL−1) on H2O2-induced intracellular ROS generation in EA.hy926 cells. (n = 3). Data are presented as means ± SD **p <0.001 vs control (CLT) group; ##p <0.001 vs. H2O2 group.
Figure 2
Figure 2
(A) Effects of NXQ (10–500 µg mL−1) on H2O2-induced intracellular ROS generation in EA.hy926 cells. (n = 3). Data are presented as means ± SD **p <0.001 vs control (CLT) group; ###p <0.001 vs. H2O2 group. (B) Effects of quercetin (10–500 µg mL−1) on H2O2-induced intracellular ROS generation in EA.hy926 cells. (n = 3). Data are presented as means ± S.D. *** p <0.0001 vs. control (CLT) group; ###p <0.001 vs. H2O2 group. (C) Effects of kaempferol (10–500 µg mL−1) on H2O2-induced intracellular ROS generation in EA.hy926 cells. (n = 3). Data are presented as means ± SD **p <0.001 vs control (CLT) group; ##p <0.001 vs. H2O2 group.

Similar articles

Cited by

References

    1. Mozaffarian D., Benjamin E.J., Go A.S., Arnett D.K., Blaha M.J., Cushman M., Das S.R., de Ferranti S., Després J.P., Fullerton H.J., et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016;133:e38–e48. doi: 10.1161/CIR.0000000000000350. - DOI - PubMed
    1. Mehta S.L., Manhas N., Raghubir R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res. Rev. 2007;54:34–66. doi: 10.1016/j.brainresrev.2006.11.003. - DOI - PubMed
    1. Seto S.-W., Chang D., Jenkins A., Bensoussan A., Kiat H. Angiogenesis in Ischemic Stroke and Angiogenic Effects of Chinese Herbal Medicine. J. Clin. Med. 2016;5:56. doi: 10.3390/jcm5060056. - DOI - PMC - PubMed
    1. Dyken M.L. What lessons have we learned in the past 40 years? Stroke. 2010;41:1073–1075. doi: 10.1161/STROKEAHA.110.584011. - DOI - PubMed
    1. Roth J.M. Baylor University Medical Center Proceedings. Volume 24. Taylor & Francis; Milton Park, UK: 2011. Recombinant tissue plasminogen activator for the treatment of acute ischemic stroke; pp. 257–259. - PMC - PubMed

LinkOut - more resources